The medical technology company’s new business unit includes AI-enabled products, BD said in a Sept. 3 news release. The acquisition of California-based Edwards Lifesciences cost $4.2 billion.
Katie Szyman, who has served as corporate vice president of the business under Edwards since 2015, is now worldwide president of BD Advanced Patient Monitoring.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.